# Accuracy of VABB Elite 10G Versus BARD 14G CNB

> **NCT04612439** · PHASE3 · UNKNOWN · sponsor: **Fudan University** · enrollment: 1470 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DEVICE:** VABB Elite 10G
- **DEVICE:** BARD 14G CNB

## Key facts

- **NCT ID:** NCT04612439
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-06-30
- **Target enrollment:** 1470 (ESTIMATED)
- **Last updated:** 2021-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04612439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04612439, "Accuracy of VABB Elite 10G Versus BARD 14G CNB". Retrieved via AI Analytics 2026-09-25 from https://api.ai-analytics.org/clinical/NCT04612439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*